A detailed history of Avanza Fonder Ab transactions in Amgen Inc stock. As of the latest transaction made, Avanza Fonder Ab holds 64,357 shares of AMGN stock, worth $22 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
64,357
Previous 57,207 12.5%
Holding current value
$22 Million
Previous $16.1 Billion 30.48%
% of portfolio
0.53%
Previous 0.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 12, 2026

BUY
$290.13 - $341.71 $2.07 Million - $2.44 Million
7,150 Added 12.5%
64,357 $21.1 Billion
Q3 2025

Oct 16, 2025

BUY
$271.18 - $309.22 $1.23 Million - $1.41 Million
4,546 Added 8.63%
57,207 $16.1 Billion
Q2 2025

Jul 14, 2025

BUY
$262.28 - $309.85 $659,109 - $778,653
2,513 Added 5.01%
52,661 $14.7 Billion
Q1 2025

Apr 15, 2025

SELL
$258.59 - $327.36 $2.32 Million - $2.94 Million
-8,974 Reduced 15.18%
50,148 $15.3 Billion
Q4 2024

Jan 15, 2025

BUY
$258.78 - $328.31 $15.3 Million - $19.4 Million
59,122 New
59,122 $15.4 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Avanza Fonder Ab Portfolio

Follow Avanza Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avanza Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Avanza Fonder Ab with notifications on news.